31
32
33
34
35
Muskens, J.L.J.M., van Dulmen, S.A., Wiersma, T., Burgers, J.S., Hek, K., Westert, G.P., Kool, R.B.
Veröffentlicht in: Muskens , J L J M , van Dulmen , S A , Wiersma , T , Burgers , J S , Hek , K , Westert , G P & Kool , R B 2022 , ' Low-value pharmaceutical care among Dutch GPs: a retrospective cohort study ' , British Journal of General Practice , vol. 72 , no. 718 , pp. E369-E377 . https://doi.org/10.3399/BJGP.2021.0625;
2022
Veröffentlicht in: Muskens , J L J M , van Dulmen , S A , Wiersma , T , Burgers , J S , Hek , K , Westert , G P & Kool , R B 2022 , ' Low-value pharmaceutical care among Dutch GPs: a retrospective cohort study ' , British Journal of General Practice , vol. 72 , no. 718 , pp. E369-E377 . https://doi.org/10.3399/BJGP.2021.0625;
2022
36
Weijenberg, Amerins, Bos, JH, Schuiling-Veninga, Catharina C M, Brouwer, Oebele F, Callenbach, Petra M C
Veröffentlicht in: Weijenberg , A , Bos , JH , Schuiling-Veninga , C C M , Brouwer , O F & Callenbach , P M C 2018 , ' Antiepileptic drug prescription in Dutch children from 2006-2014 using pharmacy-dispensing data ' , EPILEPSY RESEARCH , vol. 146 , pp. 21-27 . https://doi.org/10.1016/j.eplepsyres.2018.07.011;
2018
Veröffentlicht in: Weijenberg , A , Bos , JH , Schuiling-Veninga , C C M , Brouwer , O F & Callenbach , P M C 2018 , ' Antiepileptic drug prescription in Dutch children from 2006-2014 using pharmacy-dispensing data ' , EPILEPSY RESEARCH , vol. 146 , pp. 21-27 . https://doi.org/10.1016/j.eplepsyres.2018.07.011;
2018
37
38
Catharina CM Kager, Maaike Horsselenberg, Joke C Korevaar, Cordula Wagner, Karin Hek
Veröffentlicht in: BJGP Open, Vol 7, Iss 1 (2023);
2023
Veröffentlicht in: BJGP Open, Vol 7, Iss 1 (2023);
2023
39
40
Morales, Daniel R., Macfarlane, Tatiana, MacDonald, Thomas M., Hallas, Jesper, Ernst, Martin Thomsen, Herings, Ron M. C., Smits, Elisabeth, Overbeek, Jetty A., Mitchell, Lyn, Morant, Steven, Mackenzie, Isla, Doney, Alexander, Robertson, Chris, Bennie, Marion, Wei, Li, Nicholson, Lizzie, Morris, Carole, Flynn, Robert W. F.
Veröffentlicht in: Morales , D R , Macfarlane , T , MacDonald , T M , Hallas , J , Ernst , M T , Herings , R M C , Smits , E , Overbeek , J A , Mitchell , L , Morant , S , Mackenzie , I , Doney , A , Robertson , C , Bennie , M , Wei , L , Nicholson , L , Morris , C & Flynn , R W F 2021 , ' Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands : an interrupted time series regression analysis ' , Pharmacoepidemiology and Drug Safety , vol. 30 , no. 4 , pp. 482-491 . https://doi.org/10.1002/pds.5191;
2021
Veröffentlicht in: Morales , D R , Macfarlane , T , MacDonald , T M , Hallas , J , Ernst , M T , Herings , R M C , Smits , E , Overbeek , J A , Mitchell , L , Morant , S , Mackenzie , I , Doney , A , Robertson , C , Bennie , M , Wei , L , Nicholson , L , Morris , C & Flynn , R W F 2021 , ' Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands : an interrupted time series regression analysis ' , Pharmacoepidemiology and Drug Safety , vol. 30 , no. 4 , pp. 482-491 . https://doi.org/10.1002/pds.5191;
2021